Literature DB >> 33432084

Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent.

Rebecca M Legere1, Noah D Cohen2, Cristina Poveda3, Jocelyne M Bray1, Rola Barhoumi4, Joseph A Szule5, Andrés de la Concha-Bermejillo6, Angela I Bordin1, Jeroen Pollet7,8.   

Abstract

Vaccines and therapeutics using in vitro transcribed mRNA hold enormous potential for human and veterinary medicine. Transfection agents are widely considered to be necessary to protect mRNA and enhance transfection, but they add expense and raise concerns regarding quality control and safety. We found that such complex mRNA delivery systems can be avoided when transfecting epithelial cells by aerosolizing the mRNA into micron-sized droplets. In an equine in vivo model, we demonstrated that the translation of mRNA into a functional protein did not depend on the addition of a polyethylenimine (PEI)-derived transfection agent. We were able to safely and effectively transfect the bronchial epithelium of foals using naked mRNA (i.e., mRNA formulated in a sodium citrate buffer without a delivery vehicle). Endoscopic examination of the bronchial tree and histology of mucosal biopsies indicated no gross or microscopic adverse effects of the transfection. Our data suggest that mRNA administered by an atomization device eliminates the need for chemical transfection agents, which can reduce the cost and the safety risks of delivering mRNA to the respiratory tract of animals and humans.

Entities:  

Year:  2021        PMID: 33432084      PMCID: PMC7801524          DOI: 10.1038/s41598-020-79855-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

1.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

Authors:  Michael S D Kormann; Günther Hasenpusch; Manish K Aneja; Gabriela Nica; Andreas W Flemmer; Susanne Herber-Jonat; Marceline Huppmann; Lauren E Mays; Marta Illenyi; Andrea Schams; Matthias Griese; Iris Bittmann; Rupert Handgretinger; Dominik Hartl; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Biotechnol       Date:  2011-01-09       Impact factor: 54.908

Review 2.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

3.  Characterizing and Diminishing Autofluorescence in Formalin-fixed Paraffin-embedded Human Respiratory Tissue.

Authors:  A Sally Davis; Anke Richter; Steven Becker; Jenna E Moyer; Aline Sandouk; Jeff Skinner; Jeffery K Taubenberger
Journal:  J Histochem Cytochem       Date:  2014-04-10       Impact factor: 2.479

4.  Growth and differentiation of primary and passaged equine bronchial epithelial cells under conventional and air-liquid-interface culture conditions.

Authors:  Getu Abraham; Claudia Zizzadoro; Johannes Kacza; Christin Ellenberger; Vanessa Abs; Jana Franke; Heinz-Adolf Schoon; Johannes Seeger; Yohannes Tesfaigzi; Fritz R Ungemach
Journal:  BMC Vet Res       Date:  2011-06-07       Impact factor: 2.741

5.  Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.

Authors:  Sarah M Johler; Joanna Rejman; Shan Guan; Joseph Rosenecker
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

6.  The innate immune response of equine bronchial epithelial cells is altered by training.

Authors:  Linda Frellstedt; Philippe Gosset; Gwenola Kervoaze; Aymeric Hans; Christophe Desmet; Dimitri Pirottin; Fabrice Bureau; Pierre Lekeux; Tatiana Art
Journal:  Vet Res       Date:  2015-01-17       Impact factor: 3.683

7.  Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV.

Authors:  Kevin E Lindsay; Daryll Vanover; Merrilee Thoresen; Heath King; Peng Xiao; Peres Badial; Mariluz Araínga; Seong Bin Park; Pooja M Tiwari; Hannah E Peck; Emmeline L Blanchard; Jean M Feugang; Alicia K Olivier; Chiara Zurla; Francois Villinger; Amelia R Woolums; Philip J Santangelo
Journal:  Mol Ther       Date:  2020-01-10       Impact factor: 11.454

8.  Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection.

Authors:  Pooja Munnilal Tiwari; Daryll Vanover; Kevin E Lindsay; Swapnil Subhash Bawage; Jonathan L Kirschman; Sushma Bhosle; Aaron W Lifland; Chiara Zurla; Philip J Santangelo
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

9.  Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions.

Authors:  Edith Jansig; Stefanie Geissler; Vera Rieckmann; Anja Kuenemund; Benjamin Hietel; Mathias Schenk; Sebastian Wussow; Patrick Kreideweiss; Steffen Panzner; Christian Reinsch; Holger Cynis
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

View more
  2 in total

Review 1.  COVID-19 mRNA vaccines: Platforms and current developments.

Authors:  Gábor Tamás Szabó; Azita Josefine Mahiny; Irena Vlatkovic
Journal:  Mol Ther       Date:  2022-02-19       Impact factor: 12.910

Review 2.  mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.

Authors:  Oleksandra Chabanovska; Anne-Marie Galow; Robert David; Heiko Lemcke
Journal:  Adv Drug Deliv Rev       Date:  2021-10-13       Impact factor: 17.873

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.